CA2386527C - Forme cristalline i de la clarithromycine - Google Patents

Forme cristalline i de la clarithromycine Download PDF

Info

Publication number
CA2386527C
CA2386527C CA002386527A CA2386527A CA2386527C CA 2386527 C CA2386527 C CA 2386527C CA 002386527 A CA002386527 A CA 002386527A CA 2386527 A CA2386527 A CA 2386527A CA 2386527 C CA2386527 C CA 2386527C
Authority
CA
Canada
Prior art keywords
methylerythromycin
carbon atoms
antibiotic
solvent
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002386527A
Other languages
English (en)
Other versions
CA2386527A1 (fr
Inventor
Jih-Hua Liu
David A. Riley
Stephen G. Spanton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BGP Products Operations GmbH
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25680727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2386527(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/681,723 external-priority patent/US5858986A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of CA2386527A1 publication Critical patent/CA2386527A1/fr
Application granted granted Critical
Publication of CA2386527C publication Critical patent/CA2386527C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La présente invention concerne le nouvel antibiotique 6-O-méthylérythromycine A sous forme cristalline I, un procédé de fabrication, des compositions pharmaceutiques contenant ce composé et une méthode d'utilisation comme agent thérapeutique.
CA002386527A 1996-07-29 1997-07-25 Forme cristalline i de la clarithromycine Expired - Lifetime CA2386527C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/681,723 1996-07-29
US08/681,723 US5858986A (en) 1996-07-29 1996-07-29 Crystal form I of clarithromycin
CA002258606A CA2258606C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002258606A Division CA2258606C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Publications (2)

Publication Number Publication Date
CA2386527A1 CA2386527A1 (fr) 1998-02-05
CA2386527C true CA2386527C (fr) 2003-05-27

Family

ID=25680727

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002386527A Expired - Lifetime CA2386527C (fr) 1996-07-29 1997-07-25 Forme cristalline i de la clarithromycine
CA002419729A Expired - Lifetime CA2419729C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002419729A Expired - Lifetime CA2419729C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Country Status (1)

Country Link
CA (2) CA2386527C (fr)

Also Published As

Publication number Publication date
CA2419729C (fr) 2005-02-01
CA2419729A1 (fr) 1998-02-05
CA2386527A1 (fr) 1998-02-05

Similar Documents

Publication Publication Date Title
CA2258606C (fr) Forme cristalline ii de la clarithromycine
AU2001222619C1 (en) Processes for preparing clarithromycin polymorphs
CA2277274C (fr) Forme crystalline 0 de clarithromycine
US5844105A (en) Preparation of crystal form II of clarithromycin
AU783055B2 (en) Processes for preparing clarithromycin polymorphs and novel polymorph IV
AU733646B2 (en) Preparation of crystal form II of clarithromycin
CA2386527C (fr) Forme cristalline i de la clarithromycine
CA2386534C (fr) Forme cristalline ii de la clarithromycine et son utilite
CA2488397C (fr) Forme cristalline ii de la clarithromycine
AU777612B2 (en) Crystal form I of clarithromycin
HK1089182A (en) Crystal form i of clarithromycin
AU2005203314A1 (en) Processes for preparing clarithromycin polymorphs
ZA200204638B (en) Processes for preparing clarithromycin polymorphs and novel polymorph IV.

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170725